Opposition is growing to a European directive that would allow biotechnology companies to patent genetic material. MEPs maintain there should be an ethical dimension to the issue, which will be put to the European parliament next week.
Opposition is growing to a European directive that would allow biotechnology companies to patent genetic material. MEPs maintain there should be an ethical dimension to the issue, which will be put to the European parliament next week.